Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer ...

SARASOTA, FL, UNITED STATES, January 28, 2026 / EINPresswire.com / — Identifyn ®, a leader in super-resolution applications ...

The past decade has seen an explosion in the number of antibody-based therapeutics on the market. A huge driver of this has been the advancement of technologies that improve the time and efficiency of ...

ANTIBODY TITRATION is critical to the success of any flow cytometry experiment. This is even more so in microflow cytometric analysis of extracellular vesicles (EVs), where removing excess antibodies ...

Recent advances in analytical techniques have increased the efficiency of therapeutic antibody discovery and facilitated rapid growth of the mono-clonal antibody (mAb) market over the past 25 years.

Antibody-based therapeutics are helping patients across a wide range of disease areas, from cancer, such as Rituximab treatment of CD20-positive non-Hodgkin's lymphomas, to infectious diseases like ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the 29 th StarBright Dye, StarBright Red 670, ...

Multiplexed, multiparameter screening assays are foundational to the drug discovery process. By collecting more information, more rapidly – whether the focus antibodies, small molecules, or phenotypic ...

Flow cytometry is not just a technique. It has matured into a scientific field, one that has become virtually indispensable for most areas of biomedical research. Some of its more well-known ...